AUSTRALIA has held its head up high at the annual International Pharmaceutical Federation (FIP) World Congress of Pharmacy and Pharmaceutical Sciences, with national pharmacy initiatives recognised across 10 out of 13 Pharmaceutical Workforce Development Goals (PWDGs).
The 13 international PWDGs are the primary measurement of 21 countries' capacity and ability to implement FIP's vision of a global pharmacy workforce that can meet tomorrow's healthcare challenges.
SHPA chief executive Kristin Michaels, who attended the report's release today in Seoul, South Korea, at a special session of the 77th FIP Congress, says the inclusion of Australian examples across 10 PWDGs is a powerful endorsement of SHPA's role in driving pharmacy workforce change.
"This international analysis of national-level research, development and evaluation strategies for pharmaceutical workforces is significant, as it is the first report produced since the Nanjing roadmap," Michaels said.
Professor Ian Bates, director of FIP Education, commended Australia's performance.
"This is a remarkable achievement and I applaud SHPA for its efforts for taking a lead in the continued development of these Pharmaceutical Workforce Development Goals."
Five Australia-first SHPA initiatives were highlighted in the global report on setting international standards, including the SHPA Residency Program, the Partnership agreement with the Royal Pharmaceutical Society GB, SHPA ClinCAT, National Translational Research Collaborative and the Pharmacy Technician and Assistant Role Redesign Project.
The 77th FIP Congress in Korea concludes today.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Sep 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Sep 17
